Literature DB >> 21944010

Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe.

Stephen J O'Connor1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21944010     DOI： 10.1016/S0959-8049(11)70198-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  4 in total

1.  Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.

Authors:  Ruiguang Zhang; Yan Li; Zhongliang Wang; Lingjuan Chen; Xiaorong Dong; Xiu Nie
Journal:  Tumour Biol       Date:  2015-06-04

2.  Reduced E-Cadherin expression is a prognostic biomarker of non-small cell lung cancer: a meta-analysis based on 2395 subjects.

Authors:  Bo Yan; Wei Zhang; Li-Yan Jiang; Wen-Xin Qin; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

Review 3.  Challenge of cancer in the elderly.

Authors:  Christine Marosi; Marcus Köller
Journal:  ESMO Open       Date:  2016-04-12

4.  Women with family cancer history are at risk for poorer physical quality of life and lower self-efficacy: a longitudinal study among men and women with non-small cell lung cancer.

Authors:  Anna Banik; Ralf Schwarzer; Izabela Pawlowska; Monika Boberska; Roman Cieslak; Aleksandra Luszczynska
Journal:  Health Qual Life Outcomes       Date:  2017-04-04       Impact factor: 3.186
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.